nRichDX to Exhibit & Present Latest Products and Collaborative Research at The AACR Annual Meeting 2025 this April

The emerging leader in liquid biopsy sample prep to showcase new Revolution Plus Instrument, kits, and data at conference booth #4641

CHICAGO, March 20, 2025 /PRNewswire/ -- nRichDX, best known for the development of its Revolution Sample Prep System, will be introducing new products, presenting new data, and exhibiting at the American Association for Cancer Research (AACR) Annual Meeting 2025. Held April 25-30 at the McCormick Place Convention Center in Chicago, the conference is dedicated to exploring and recognizing the latest discoveries in cancer research. nRichDX will exhibit in booth #4641, and co-present a poster with collaborator PacBio on April 29. Exhibits open at 12:00 Noon on Sunday April 27 and close at 12:00 Noon on Wednesday April 30.

AACR Annual Meeting 2024 attendees considering liquid biopsy assays and the extraction of cfDNA, cfRNA, circulating cell-free total nucleic acid (cfTNA), or the enrichment of circulating tumor cells (CTCs), are encouraged to visit the nRichDX booth to see the latest liquid biopsy sample prep solutions, talk with liquid biopsy sample prep experts, and investigate data on how extraction of higher yields of liquid biopsy analytes from samples can increase assay performance.

"nRichDX is setting the standard for liquid biopsy sample preparation performance, workflow, and flexibility with solutions engineered to easily deliver the highest yields of rare analytes from an unequaled range of liquid biopsy sample types and sample volumes," said William Curtis, CEO of nRichDX. "nRichDX is proud to again support and participate in this year's AACR Annual Meeting."

nRichDX is featuring its new Revolution Plus™ Sample Prep System. nRichDX is also featuring two new nRicher Cartridges. The new nRicher Cartridges enable single extractions from the broadest sample input volume range of any commercially available kit (1 mL to 100 mL), eliminating yield-lowering sample or eluate pooling and sample transfer steps required by other sample prep methods – especially at sample volumes above 4 mL. 

A recognized leader in providing high quality analyte yields from all sample input volumes, nRichDX significantly outperforms the market in maximizing rare analyte yield from larger volume samples like urine, plasma, blood and other biofluids. Attendees interested in how the Revolution Plus System works are encouraged to schedule an in-booth demo.

To meet with nRichDX staff at the meeting or schedule an in-booth demo, attendees are encouraged to schedule an appointment. To find the latest information about nRichDX's schedule at the AACR Annual Meeting 2025, please visit https://www.nrichdx.com/aacr2025

About nRichDX:

nRichDX^® provides kits and automated solutions for isolating cfDNA, cfRNA, and CTCs. The patented Revolution Sample Prep System^™ is engineered specifically for liquid biopsy applications and isolating analytes from blood, plasma, urine, and other biofluids. It is the first and only high-yield, high-recovery, IVD-labeled sample prep platform to process from as little as 1 mL to 100 mL in a single extraction using the company's patented Revolution nRicher™ Cartridges. Unlike other methods, Revolution sample prep doesn't require yield-lowering sample preconcentration, eluate pooling, sample transfer, or sample re-elution steps. nRichDX helps solve one of precision medicine's greatest problems – – inaccurate or incomplete diagnostic results for liquid biopsy-based applications due to insufficient analyte. nrichdx.com.

Media Contact nRichDX: Tom Curtis
Phone: (949)341-1980 x6
Email: [email protected]

SOURCE nRichDX